Nutriband Overview

  • Status
  • Public

  • Employees
  • 3

Employees

  • Stock Symbol
  • NTRB

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $4.23
  • (As of Monday Closing)

Nutriband General Information

Description

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Contact Information

Website
www.nutriband.com
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Corporate Office
  • 121 South Orange Avenue
  • Suite 1500
  • Orlando, FL 32801
  • United States
+1 (407)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Vertical(s)
LOHAS & Wellness, Manufacturing
Corporate Office
  • 121 South Orange Avenue
  • Suite 1500
  • Orlando, FL 32801
  • United States
+1 (407)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nutriband Stock Performance

As of 13-Jan-2025, Nutriband’s stock price is $4.23. Its current market cap is $45.9M with 11.1M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.23 $4.13 $2.22 - $9.60 $45.9M 11.1M 25.9K -$0.71

Nutriband Financials Summary

As of 31-Oct-2024, Nutriband has a trailing 12-month revenue of $2.02M.

In Thousands,
USD 		TTM 31-Oct-2024 FY 2024 31-Jan-2024 FY 2023 31-Jan-2023 FY 2022 31-Jan-2022
EV 62,140 23,069 25,974 28,712
Revenue 2,022 2,085 2,080 1,422
EBITDA (6,673) (5,139) (4,145) (5,739)
Net Income (6,847) (5,485) (4,483) (6,176)
Total Assets 12,543 7,517 9,456 12,740
Total Debt 200 241 186 135
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nutriband Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nutriband‘s full profile, request access.

Request a free trial

Nutriband Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is
Drug Discovery
Orlando, FL
3 As of 2024

East Rutherford, NJ
 

Chenove, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nutriband Competitors (7)

One of Nutriband’s 7 competitors is Cambrex, a Private Equity-Backed company based in East Rutherford, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cambrex Private Equity-Backed East Rutherford, NJ
AdhexPharma Corporation Chenove, France
Helsinn Healthcare Corporation Lugano, Switzerland
Active Iron Venture Capital-Backed Cork, Ireland
CordenPharma Private Equity-Backed Plankstadt, Germany
You’re viewing 5 of 7 competitors. Get the full list »

Nutriband Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Nutriband Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200113845-A1 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014
US-20220125739-A1 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014
US-11246840-B2 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014
US-11759431-B2 Abuse and misuse deterrent transdermal systems Active 22-Jan-2014
US-20240000720-A1 Abuse and misuse deterrent transdermal systems Pending 22-Jan-2014 A61K9/7084
To view Nutriband’s complete patent history, request access »

Nutriband Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nutriband Acquisitions (5)

Nutriband’s most recent deal was a Merger/Acquisition with Active Intelligence (USA). The deal was made on 31-Aug-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Active Intelligence (USA) 31-Aug-2020 Merger/Acquisition Medical Supplies
Pocono Coated Products 31-Aug-2020 Merger/Acquisition Pharmaceuticals
Carmel Biosciences 19-Nov-2018 Merger/Acquisition Pharmaceuticals
4P Therapeutics 01-Aug-2018 Merger/Acquisition Drug Delivery
Advanced Health Brands 22-May-2017 Merger/Acquisition Biotechnology
To view Nutriband’s complete acquisitions history, request access »

Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Active Intelligence (USA) Cherryville, NC 2017
Pocono Coated Products Cherryville, NC 2004

Nutriband FAQs

  • Where is Nutriband headquartered?

    Nutriband is headquartered in Orlando, FL.

  • What is the size of Nutriband?

    Nutriband has 3 total employees.

  • What industry is Nutriband in?

    Nutriband’s primary industry is Drug Discovery.

  • Is Nutriband a private or public company?

    Nutriband is a Public company.

  • What is Nutriband’s stock symbol?

    The ticker symbol for Nutriband is NTRB.

  • What is the current stock price of Nutriband?

    As of 13-Jan-2025 the stock price of Nutriband is $4.23.

  • What is the current market cap of Nutriband?

    The current market capitalization of Nutriband is $45.9M.

  • What is Nutriband’s current revenue?

    The trailing twelve month revenue for Nutriband is $2.02M.

  • Who are Nutriband’s competitors?

    Cambrex, AdhexPharma, Helsinn Healthcare, Active Iron, and CordenPharma are some of the 7 competitors of Nutriband.

  • What is Nutriband’s annual earnings per share (EPS)?

    Nutriband’s EPS for 12 months was -$0.71.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »